Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes  

作　　者：Maram Alenzi Mohammad Almeqdadi 

机构地区：[1]Department of Medicine,St.Elizabeth’s Medical Center,Boston University,MA 02135,United States [2]Department of Transplant and Hepatobiliary Disease,Tufts Medical Center,Boston,MA 02111,United States

出　　处：《World Journal of Hepatology》2024年第8期1091-1098,共8页世界肝病学杂志（英文版）（电子版）

摘　　要：Hepatitis C virus(HCV)is a significant public health challenge globally,with substantial morbidity and mortality due to chronic liver disease.Despite the availability of highly effective and well-tolerated direct-acting antiviral therapies,widespread disparities remain in hepatitis C screening,access to treatment,linkage to care,and therapeutic outcomes.This review article synthesizes evi-dence from various studies to highlight the multifactorial nature of these dispari-ties,which affects ethnic minorities,people with lower socioeconomic status,in-dividuals with substance use disorders,and those within correctional facilities.The review also discusses policy implications and targeted strategies needed to overcome barriers and ensure equitable care for all individuals with HCV.Recom-mendations for future research to address gaps in knowledge and evaluation of the effectiveness of interventions designed to reduce disparities are provided.

关 键 词：Hepatitis C virus disparities Access to care Health equity Healthcare policy Patient education 

分 类 号：R512.63[医药卫生—内科学]